An Observational Study of Patients With Dermatologic Disease
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 2,000,000
- 试验地点
- 4
- 主要终点
- To assess safety and effectiveness of DD treatments and treatments for complications of any dermatologic disease
研究概览
简要总结
TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual clinical practice in the United States and addresses important clinical questions regarding the management of DD by collecting and analyzing data from patients at academic medical centers and community medical practices and/or data from providers who treat them.
详细描述
TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual clinical practice in the United States and addresses important clinical questions regarding the management of DD by collecting and analyzing data from patients at academic medical centers and community medical practices and/or data from providers who treat them. TARGET-DERM+ is designed to develop a large, robust database of real-world data regarding the natural history, management, and health outcomes related to the care of DD of diverse etiologies and practice settings. The study is also designed to establish learning health networks focused on quality of care for patients with DD.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult or pediatric participants managed for DD invited to participate OR a provider who treats patients with these conditions. Informed consent is required for all Engaged Cohort participants.
- •Adult or pediatric participants at the time of enrollment with a diagnosis of DD by ICD code or other relevant healthcare code as part of the EHR interface.
排除标准
- •Participant withdrew consent; Failure to complete activities as required per the cohort clarification letter.
研究组 & 干预措施
Disease Cohort
Adult patients and patients under the age of majority with a diagnosis of DD by ICD or other relevant healthcare code in the EHR interface.
Engaged Cohort
Adult patients and patients under the age of majority diagnosed and managed for DD invited to participate OR HCPs who treat patients with these conditions.
- Informed consent is required for all participants in an Engaged Cohort.
- Willing to complete required Engaged Cohort activities.
结局指标
主要结局
To assess safety and effectiveness of DD treatments and treatments for complications of any dermatologic disease
时间窗: 15 years
The study will evaluate the characteristics of patients receiving various treatments, effectiveness of treatment, and medical events that develop while receiving treatment for DD
To characterize the natural history of disease in patients with dermatologic disease from various etiologies
时间窗: 15 years
A detailed analysis of available demographics (age, race, sex, country of birth, insurance status), medications, co-morbidities, and medical history from sites across the US will inform the profile for this patient population.
To establish learning health networks focused on quality of care for patients
时间窗: 15 years
Identify deficiencies and best practices in care of patients with DD. • Evaluate outcomes from targeted learning content in the management of patients with DD.
次要结局
- To evaluate provider management practices in the treatment of patients with DD(15 years)
- To evaluate longitudinal and patient reported outcomes in DD(15 years)